These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 6006070)

  • 41. Controlled drug trial of B.663 compared with DDS. Preliminary (48 week) report.
    Tolentino JG; Rodriquez JN; Abalos RM
    Int J Lepr Other Mycobact Dis; 1971; 39(3):738-41. PubMed ID: 5169924
    [No Abstract]   [Full Text] [Related]  

  • 42. Sulfone resistance and leprosy control.
    Bergel M
    Nihon Rai Gakkai Zasshi; 1981; 50(1):51-2. PubMed ID: 7298547
    [No Abstract]   [Full Text] [Related]  

  • 43. Lamprene: first results of treatment in the Netherlands in a group of 6 leprosy patients.
    Hogerzeil LM
    Dermatologica; 1971; 143(6):339-44. PubMed ID: 5150817
    [No Abstract]   [Full Text] [Related]  

  • 44. [2 cases of paucibacillary leprosy resistant to dapsone].
    Janssens L
    Acta Leprol; 1982; (86-87):181-3. PubMed ID: 6815986
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Trial of a new leprostatics (B-663) in the treatment of lepromatous leprosy].
    Renders A
    Ann Soc Belges Med Trop Parasitol Mycol; 1968; 48(6):625-35. PubMed ID: 5759964
    [No Abstract]   [Full Text] [Related]  

  • 46. [Transition of leprous occular changes under chemotherapy].
    Arai M
    Keisei Geka; 1967 Apr; 10(2):Suppl:7-9. PubMed ID: 6070441
    [No Abstract]   [Full Text] [Related]  

  • 47. [Mechanism of action of sulfones in leprosy; activity of monoisopropyl sulfone and diisopropyl sulfone administered by mouth].
    DEHEZ F; FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1956 Jul; 17(400):1-8. PubMed ID: 13395621
    [No Abstract]   [Full Text] [Related]  

  • 48. New drug for leprosy.
    Br Med J; 1969 Mar; 1(5647):797-8. PubMed ID: 5774074
    [No Abstract]   [Full Text] [Related]  

  • 49. [Control of leprosy: fantasies and possibilities].
    Browne SG
    Bull Mem Acad R Med Belg; 1980; 135(3):208-18. PubMed ID: 7004552
    [No Abstract]   [Full Text] [Related]  

  • 50. [Histological and bacteriological changes in lepromatous leprosy after treatment with diamino-diphenyl-sulfone (sulfone mère)].
    NICOLAU SG; VULCAN P
    Arch Klin Exp Dermatol; 1958; 207(5):486-98. PubMed ID: 13595786
    [No Abstract]   [Full Text] [Related]  

  • 51. [Treatment of leprosy by sulfones and delayed action sulfonamides. Comparison of therapeutic results in 100 cases].
    Faye I; Privat Y; Bellossi A
    Bull Soc Med Afr Noire Lang Fr; 1968; 13(1):119-24. PubMed ID: 5713742
    [No Abstract]   [Full Text] [Related]  

  • 52. Maintenance of leprosy endemicity and bacterial positivity of lepromatous patients under treatment with sulfones.
    Bechelli LM; Dominguez VM
    Int J Lepr Other Mycobact Dis; 1971; 39(2):461. PubMed ID: 5169809
    [No Abstract]   [Full Text] [Related]  

  • 53. The treatment of leprosy and its acute complications.
    Jopling WH
    Trop Doct; 1973 Jan; 3(1):8-11. PubMed ID: 4120944
    [No Abstract]   [Full Text] [Related]  

  • 54. [Treatment of leprosy with diucifon].
    Goloshchapov NM; Steklovskiĭ VK; Filipskikh TP; Khromova EB
    Vestn Dermatol Venerol; 1983 Apr; (4):67-71. PubMed ID: 6868818
    [No Abstract]   [Full Text] [Related]  

  • 55. [Therapeutic activities of monoisopropyl sulfone and diisopropyl sulfone in leprosy].
    FLOCH H
    Publ Inst Pasteur Guyane Fr Inini; 1956 Jul; 17(401):1-6. PubMed ID: 13395622
    [No Abstract]   [Full Text] [Related]  

  • 56. [Chemotherapy of leprosy. II. Sulfones and sulfonamides].
    Leiker DL
    Ned Tijdschr Geneeskd; 1980 Jan; 124(2):46-8. PubMed ID: 7374822
    [No Abstract]   [Full Text] [Related]  

  • 57. A preliminary report on the use of B663 in the treatment of Chinese leprosy patients with chronic reaction.
    Warren AG
    Lepr Rev; 1968 Apr; 39(2):61-6. PubMed ID: 5653308
    [No Abstract]   [Full Text] [Related]  

  • 58. Length of continued treatment of an inactive case of leprosy.
    Dharmendra
    Lepr India; 1976 Jul; 48(3):212-6. PubMed ID: 1022967
    [No Abstract]   [Full Text] [Related]  

  • 59. [Prevention of the leprous reaction].
    Bergel M
    Ther Ggw; 1971 Oct; 110(10):1471-6. PubMed ID: 5003860
    [No Abstract]   [Full Text] [Related]  

  • 60. Clofazimine in leprosy.
    Schulz EJ
    Br Med J; 1972 Mar; 1(5802):749. PubMed ID: 5015339
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.